SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending as its CEO made a significant insider stock purchase, signaling strong confidence, while rumors of a potential partnership with OpenAI to sell ads are igniting community speculation about a major growth catalyst for the recently oversold ad-tech stock.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI Corp. is trending following its strong Q4 earnings report, reaffirming impressive future revenue growth guidance, and securing significant new defense contracts including missile propulsion systems and multi-domain swarming autonomy projects. The community is actively discussing the company's potential as a transformative player in defense AI and drone technology, with many likening it to early-stage industry leaders, further amplified by high short interest and expectations for a major upside move.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following its Q4 results and reaffirmed conservative 2026 guidance, which has ignited widespread community frustration over perceived management missteps and undervaluation. Despite the board authorizing a share buyback aimed at boosting value and potentially combating persistent short interest, investors are keenly awaiting upcoming Rezzayo data and new customer partnerships as crucial catalysts.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community eagerly anticipates the long-awaited Phase 3 REGAL trial results for its AML immunotherapy, with many speculating a big pharma buyout is imminent due to unprecedented patient survival rates and unusual executive silence. Investors are betting on a "near-cure" and significant upside, despite persistent short interest leading to a heated debate between bulls and bears.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following a strong earnings report that exceeded expectations and significantly raised future guidance, fueled by robust demand for its AI chips and a new partnership with OpenAI. The company's optimistic forecast for AI revenue is sparking intense discussion, with many anticipating continued growth, while some express caution about valuation and broader market conditions affecting the post-earnings momentum.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following strong Q4 2025 earnings that showcased significant revenue growth and positive adjusted EBITDA, alongside optimistic 2026 guidance. The community is actively discussing the company's superior silicon anode battery technology as crucial for the rapidly expanding defense and drone markets, buoyed by progress in US-based manufacturing.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma (HELP) is trending as the community reacts to a significant stock sell-off despite positive topline Phase 2 results for its generalized anxiety disorder treatment, HLP004, with many investors debating if the market is overreacting to the strong data.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending following its Q4 earnings, which initially saw confusion over EPS figures before being clarified as an inline beat with robust revenue growth and record customer assets. The community is sharply divided, debating whether ongoing dilution concerns and historical stock performance outweigh these strong operational metrics, with many perceiving the stock as deeply undervalued in the fintech brokerage space.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing (RGTI) is trending after a recent earnings report revealed low revenue and substantial losses, intensifying community debate over its high market valuation. While many express strong skepticism about the company's financials, a segment of investors remains long-term bullish on its quantum computing potential and existing cash reserves.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is experiencing extreme volatility and massive trading volume as escalating Middle East tensions and concerns over oil supply routes drive crude prices higher. The community is actively debating the stock's short squeeze potential, with bullish traders eyeing significant upside while others caution about profit-taking and its recent offering price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ludwig Enterprises Inc, operates as a biotech and healthcare holding company. The company is a medical technology holding company with its subsidiaries, Precision Genomics, Inc. and MyRNA for Life, Inc. The company, with its mRNA genetic technology, uses inflammatory genetic markers to assess the occurrence of inflammatory-driven diseases, as well as to monitor treatment responses. The company was founded on February 11, 1988 and is headquartered in Miami, FL.

Ludwig Enterprises Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COST earnings Thursday?

Current Price	$0.0349
Prev Close	$0.0221
Open	$0.028
Dividend Yield	0.00%
50-Day Moving Average	$0.0468
Beta	-0.42
Avg. Volume	17,313.74
PE Ratio	-1.65

52-Week High	$0.155
52-Week Low	$0.0205
Market Capitalization	$5.67M
EPS (Annual)	-$0.0203
Price to Book	-1.71
Revenue Per Employee	$72.33

LUDG
Ludwig Enterprises, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest LUDG News

LUDGLudwig Enterprises, Inc.